Viwat Visuthikraisee 8/7/24 Viwat Visuthikraisee 8/7/24 First patient in Asia receives AU409 following the ongoing first-in-human clinical trial in the US for liver cancer Read More Yolandi Stanek 9/27/23 Yolandi Stanek 9/27/23 Seven AI/ML for Life Sciences Companies Identified as Innovators in New Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report Read More Yolandi Stanek 9/14/23 Yolandi Stanek 9/14/23 AI-Biopharma Auransa Announces Successful First Patient Dosed in Phase 1 Clinical Trial for Liver Cancer Read More Yolandi Stanek 3/23/23 Yolandi Stanek 3/23/23 USC Norris collaborates with Auransa on clinical trial of new targeted treatment for liver cancer and other solid tumors Read More Yolandi Stanek 11/3/22 Yolandi Stanek 11/3/22 FDA Acceptance of Auransa's IND Application for AU409 for Treatment of Patients with Hepatocellular Carcinoma Read More Yolandi Stanek 8/9/22 Yolandi Stanek 8/9/22 POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI Read More Yolandi Stanek 6/4/21 Yolandi Stanek 6/4/21 Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases Read More Yolandi Stanek 9/23/19 Yolandi Stanek 9/23/19 AU-409: a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma Read More Yolandi Stanek 12/19/18 Yolandi Stanek 12/19/18 Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia Read More
Viwat Visuthikraisee 8/7/24 Viwat Visuthikraisee 8/7/24 First patient in Asia receives AU409 following the ongoing first-in-human clinical trial in the US for liver cancer Read More
Yolandi Stanek 9/27/23 Yolandi Stanek 9/27/23 Seven AI/ML for Life Sciences Companies Identified as Innovators in New Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report Read More
Yolandi Stanek 9/14/23 Yolandi Stanek 9/14/23 AI-Biopharma Auransa Announces Successful First Patient Dosed in Phase 1 Clinical Trial for Liver Cancer Read More
Yolandi Stanek 3/23/23 Yolandi Stanek 3/23/23 USC Norris collaborates with Auransa on clinical trial of new targeted treatment for liver cancer and other solid tumors Read More
Yolandi Stanek 11/3/22 Yolandi Stanek 11/3/22 FDA Acceptance of Auransa's IND Application for AU409 for Treatment of Patients with Hepatocellular Carcinoma Read More
Yolandi Stanek 8/9/22 Yolandi Stanek 8/9/22 POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI Read More
Yolandi Stanek 6/4/21 Yolandi Stanek 6/4/21 Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases Read More
Yolandi Stanek 9/23/19 Yolandi Stanek 9/23/19 AU-409: a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma Read More
Yolandi Stanek 12/19/18 Yolandi Stanek 12/19/18 Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia Read More
